View in EDS HTML Full Text PDF Full Text

The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.

Saved in:
Bibliographic Details
Title: The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.
Authors: Bourgeois AL; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Scott DA; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States., Baqar S; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Tribble DR; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States., Svennerholm AM; Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden., Walker RI; Center for Vaccine Innovation and Access, PATH, Washington, DC, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1805998. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026).
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42088495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bourgeois+AL%22">Bourgeois AL</searchLink>; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.<br /><searchLink fieldCode="AU" term="%22Scott+DA%22">Scott DA</searchLink>; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Baqar+S%22">Baqar S</searchLink>; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Tribble+DR%22">Tribble DR</searchLink>; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Svennerholm+AM%22">Svennerholm AM</searchLink>; Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Walker+RI%22">Walker RI</searchLink>; Center for Vaccine Innovation and Access, PATH, Washington, DC, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1805998. <i>Date of Electronic Publication: </i>2026 Apr 20 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42088495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1805998
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1805998
    Titles:
      – TitleFull: The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bourgeois AL
      – PersonEntity:
          Name:
            NameFull: Scott DA
      – PersonEntity:
          Name:
            NameFull: Baqar S
      – PersonEntity:
          Name:
            NameFull: Tribble DR
      – PersonEntity:
          Name:
            NameFull: Svennerholm AM
      – PersonEntity:
          Name:
            NameFull: Walker RI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 04
              Text: 2026 Apr 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1